Electromed (ELMD) Assets Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.86% |
| Dec 31, 2025 | 8.92% |
| Sep 30, 2025 | 9.29% |
| Jun 30, 2025 | 10.11% |
| Mar 31, 2025 | 9.73% |
| Dec 31, 2024 | 10.67% |
| Sep 30, 2024 | 10.05% |
| Jun 30, 2024 | 12.18% |
| Mar 31, 2024 | 12.04% |
| Dec 31, 2023 | 11.81% |
| Sep 30, 2023 | 9.88% |
| Jun 30, 2023 | 10.83% |
| Mar 31, 2023 | 12.04% |
| Dec 31, 2022 | 11.80% |
| Sep 30, 2022 | 11.58% |
| Jun 30, 2022 | 12.40% |
| Mar 31, 2022 | 12.25% |
| Dec 31, 2021 | 13.03% |
| Sep 30, 2021 | 13.98% |
| Jun 30, 2021 | 12.52% |
| Mar 31, 2021 | 13.19% |
| Dec 31, 2020 | 13.46% |
| Sep 30, 2020 | 14.30% |
| Jun 30, 2020 | 13.82% |
| Mar 31, 2020 | 14.18% |
| Dec 31, 2019 | 13.55% |
| Sep 30, 2019 | 12.91% |
| Jun 30, 2019 | 13.23% |
| Mar 31, 2019 | 11.46% |
| Dec 31, 2018 | 9.09% |
| Sep 30, 2018 | 9.58% |
| Jun 30, 2018 | 9.31% |
| Mar 31, 2018 | 5.18% |
| Dec 31, 2017 | 4.37% |
| Sep 30, 2017 | 2.57% |
| Jun 30, 2017 | 1.97% |
| Mar 31, 2017 | 1.01% |
| Dec 31, 2016 | -0.02% |
| Sep 30, 2016 | -1.42% |
| Jun 30, 2016 | -0.28% |